Litigation Healthcare and Pharmaceutical Enforcement Corporate Governance and Investigations Foreign Corrupt Practices Act and Anti-Corruption Investigations and White Collar Defense Antitrust Investigations Internal Investigations
Assistant United States Attorney, U.S. Attorney's Office for the District of Maryland
District of Columbia Maryland
J.D., University of Pennsylvania Law School, 1984 B.A., magna cum laude, Washington College, 1981
Honorable Marvin H. Smith, Maryland Court of Appeals, 1984 - 1985
American Bar Association
Federal Bar Association
Maryland Bar Association
Fourth Circuit Judicial Conference
Geoff Garinther is a former federal prosecutor with 30 years of trial experience whose practice focuses on defending corporations and individuals accused of white collar crime - particularly where there are allegations of political corruption or healthcare fraud - and on conducting independent investigations for the boards of public companies. He is also the chair of Venable's Litigation Division and a member of the firm's Management Committee.
Geoff has tried nearly 50 cases to verdict in his career, both as a former Assistant United States Attorney in Maryland and in private practice. He uses this experience first and foremost to help his clients avoid prosecution whenever possible. Geoff is also well known for his corporate governance experience, which includes internal investigations for corporate directors and Zapata investigations for independent directors dealing with shareholder litigation.
Geoff recently successfully defended a prominent DC law firm against an effort to obtain discovery from four of its lawyers who had conducted an internal investigation for a multi-national pharmaceutical company.
Since 2009, he has been pursuing shareholder litigation against three former officers of Tampa-based WellCare Health Plans, Inc., following a Zapata investigation into the claims on behalf of an independent director of WellCare.
As reported in the "Big Suits" section of the March 2012 American Lawyer, Geoff and his partner Warren Hamel led a Venable team in a five-year investigation and negotiation of criminal and civil claims against an India-based generic drug manufacturer, Ranbaxy, that resulted in a settlement allowing the company to exercise its first-to-file right to market Atorvastatin (generic Lipitor) in the United States.
Over the past three years, Geoff has successfully defended executives - two based in Asia and one in the U.S. - in three different DOJ Antitrust Division investigations.
Geoff is a member of the Criminal Justice Act panel for the U.S. District Court for the District of Maryland, through which he represents indigent criminal defendants. He also chairs the joint state and federal bar associations' liaison committee to that court, as well as court committees dealing with magistrate-judge selection and attorneys' fee guidelines. He is a permanent member of the Fourth Circuit Judicial Conference. He occasionally appears as a television analyst on criminal matters, has written extensively on corporate governance and homeland security issues, and has lectured, as a defense lawyer, at the DOJ's National Advocacy Center.